Sign in
4

Changes in Ownership

MoonLake Immunotherapeutics Filed Acc 0001213900-25-052365

Options or other derivatives

  • Director acquired 6,682 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Phillips Andrew John · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-06-05 Grant or award : show line 1 in the form Option to Buy +6,682 6,682 D
Loading xslF345X05/ownership.xml…